3-hydroxyflavone has been researched along with Carcinoma, Renal Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HR; Chiou, HL; Hsieh, MH; Hsieh, YH; Lin, CL; Tsai, JP; Yang, SF | 1 |
1 other study(ies) available for 3-hydroxyflavone and Carcinoma, Renal Cell
Article | Year |
---|---|
Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.
Topics: ADAM Proteins; Antineoplastic Agents; Carcinoma, Renal Cell; Cathepsins; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Humans; Kidney Neoplasms; MAP Kinase Signaling System; Membrane Proteins; Molecular Structure; Neoplasm Metastasis; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |